METHODS OF TREATING OR PREVENTING INSULIN RESISTANCE AND ASSOCIATED DISEASES AND CONDITIONS Read more about METHODS OF TREATING OR PREVENTING INSULIN RESISTANCE AND ASSOCIATED DISEASES AND CONDITIONS US Application 61/584,526Filed on 2012-01-09
Novel Chalcone Derivative As Potent Activator Of Nrf2 Signaling Read more about Novel Chalcone Derivative As Potent Activator Of Nrf2 Signaling US Application 61/500,272Filed on 2011-06-23
Novel Chalcone Derivative As Potent Activator Of Nrf2 Signaling Read more about Novel Chalcone Derivative As Potent Activator Of Nrf2 Signaling US Application 61/446,716Filed on 2011-02-25
Auto-recognizing Therapeutic R/DNA Chimeric Nanoparticles (NP): A Novel Concept For HIV Treatment Read more about Auto-recognizing Therapeutic R/DNA Chimeric Nanoparticles (NP): A Novel Concept For HIV Treatment US Application 61/561,257Filed on 2011-11-17
Development Of Therapeutic RNA Switches To Eradicate Viral Reservoirs In HIV-Infected Patients Read more about Development Of Therapeutic RNA Switches To Eradicate Viral Reservoirs In HIV-Infected Patients US Application 61/561,247Filed on 2011-11-17
A NOVEL INTERFERON-ANALOG (IFNAN) PROTEIN, RELATED NUCLEIC ACID MOLECULES, AND USES THEREOF Read more about A NOVEL INTERFERON-ANALOG (IFNAN) PROTEIN, RELATED NUCLEIC ACID MOLECULES, AND USES THEREOF US Application 61/616,664Filed on 2012-03-28
Vascular Endothelial Growth Factor Antagonists And Methods For Their Use Read more about Vascular Endothelial Growth Factor Antagonists And Methods For Their Use US Application 61/639,230Filed on 2012-04-27
GENE EXPRESSION SIGNATURES OF NEOPLASM RESPONSIVENESS TO THERAPY Read more about GENE EXPRESSION SIGNATURES OF NEOPLASM RESPONSIVENESS TO THERAPY US Application 61/558,402Filed on 2011-11-10
ANTI-CD22 CHIMERIC ANTIGEN RECEPTORS.. Read more about ANTI-CD22 CHIMERIC ANTIGEN RECEPTORS.. US Application 61/549,516Filed on 2011-10-20
HYBRID DIAZENIUMDIOLATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER Read more about HYBRID DIAZENIUMDIOLATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER US Application 61/549,862Filed on 2011-10-21